Cardiovascular Advances in Research and Opportunities Legacy Act
Summary
The Cardiovascular Advances in Research and Opportunities Legacy Act (HR1193) was signed into law on December 20, 2022, authorizing NIH research and HHS education activities on valvular heart disease. The bill authorizes no specific funding amount and does not mandate private-sector spending, making its direct market impact minimal. Diagnostic and imaging companies like GE HealthCare ($GEHC), Quest Diagnostics ($DGX), and Labcorp ($LH) may see indirect, marginal benefits from increased research activity, but no concrete revenue stream is established.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The bill is already signed into law—no further legislative steps remain.
- 2.It authorizes research and education activities but provides no specific funding amount.
- 3.Direct market impact is minimal; any benefits to diagnostic or imaging companies are indirect and speculative.
Market Implications
The bill has no direct market implications. Diagnostic and imaging companies may see minor, indirect benefits from increased NIH research activity, but no concrete revenue catalyst exists. Investors should focus on other legislative or market drivers for these tickers.
Full Analysis
The Cardiovascular Advances in Research and Opportunities Legacy Act (HR1193) was signed into law by The President on December 20, 2022, as Public Law 117-244. The bill directs the NIH, in consultation with the NHLBI, to support or conduct research on valvular heart diseases, including advanced imaging and risk factor assessment. It also requires HHS to develop best practices and carry out education and awareness activities. However, the bill authorizes no specific dollar amount for these activities—it is an authorization bill, not an appropriations bill. Actual funding depends on subsequent appropriations by Congress, which have not been specified. The bill's primary mechanism is to enable NIH to use existing funds for this research, not to create a new funding stream. For investors, this means no direct revenue catalyst for healthcare companies. The bill's impact on diagnostic and imaging companies like GE HealthCare ($GEHC), Quest Diagnostics ($DGX), and Labcorp ($LH) is indirect and speculative—increased research activity could marginally boost demand for imaging equipment and diagnostic tests, but the effect is small and uncertain. No convergence signals were identified in the provided data. The bill's legislative history shows broad bipartisan support (183 cosponsors) and a companion bill in the Senate (S1133), but its passage is already complete. The key takeaway is that this is a low-impact, already-enacted law with no near-term market implications.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Women's Health to Improve Outcomes in All Phases of Life
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →